Kymera Therapeutics, Inc. (KYMR)
USD 39.06
(-7.66%)
USD 39.06
(-7.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -102.82 Million | -153.08 Million | -128.94 Million | 88.13 Million | 17.9 Million | -17.86 Million |
| Net Income | -146.96 Million | -154.8 Million | -100.21 Million | -45.59 Million | -41.24 Million | -21.46 Million |
| Depreciation & Amortization | 3.56 Million | 2.97 Million | 2.39 Million | 1.76 Million | 825 Thousand | 205 Thousand |
| Deferred income taxes | -2.68 Million | - | - | 1.57 Million | - | - |
| Stock-based compensation | 43.11 Million | 35.48 Million | 24.97 Million | 5.19 Million | 1.19 Million | 648 Thousand |
| Change in working capital | 2.68 Million | -37.62 Million | -61.92 Million | 124.86 Million | 56.68 Million | 2.3 Million |
| Other non-cash items | -2.54 Million | 889 Thousand | 5.82 Million | 332 Thousand | 443 Thousand | 443 Thousand |
| Investing Cash Flow | 139.88 Million | 20.51 Million | -99.83 Million | -422.58 Million | -16.48 Million | -1.35 Million |
| Investments in PPE | -34.48 Million | -2.83 Million | -1.59 Million | -9.09 Million | -532 Thousand | -1.35 Million |
| Acquisitions | -5.22 Million | -20.51 Million | 5.8 Million | 413.49 Million | - | - |
| Investment purchases | -189.15 Million | -445.97 Million | -456.4 Million | -529.38 Million | -15.95 Million | - |
| Sales/Maturities of investments | 363.51 Million | 469.32 Million | 358.16 Million | 115.89 Million | - | - |
| Other Investing Activities | 5.22 Million | 20.51 Million | -5.8 Million | -413.49 Million | -15.95 Million | - |
| Financing Cash Flow | 4.19 Million | 152.99 Million | 250.28 Million | 289.26 Million | 34.91 Million | 52.93 Million |
| Debt repayment | -76 Thousand | -1.13 Million | -849 Thousand | -554 Thousand | -371 Thousand | -295 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.26 Million | 149.82 Million | 243.1 Million | 196.67 Million | 35.28 Million | 53.22 Million |
| Other Financing Activities | 4.26 Million | 4.3 Million | 8.02 Million | 93.14 Million | 34.91 Million | 53.22 Million |
| Accounts receivables | -15 Million | -2.4 Million | 577 Thousand | -577 Thousand | 148 Thousand | -148 Thousand |
| Accounts payables | 2.03 Million | 253 Thousand | 54 Thousand | 990 Thousand | 904 Thousand | 824 Thousand |
| Inventory | 23.37 Million | 2.4 Million | 8.7 Million | 6.87 Million | -148 Thousand | - |
| Other working capital | -7.72 Million | -37.87 Million | -71.26 Million | 117.57 Million | 55.78 Million | 1.48 Million |
| Cash at beginning of period | 74.52 Million | 54.09 Million | 32.59 Million | 77.78 Million | 41.45 Million | 7.74 Million |
| Cash at end of period | 115.77 Million | 74.52 Million | 54.09 Million | 32.59 Million | 77.78 Million | 41.45 Million |
| Capital Expenditure | -34.48 Million | -2.83 Million | -1.59 Million | -9.09 Million | -532 Thousand | -1.35 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 41.25 Million | 20.43 Million | 21.49 Million | -45.19 Million | 36.33 Million | 33.71 Million |
| Free Cash Flow | -137.3 Million | -155.92 Million | -130.54 Million | 79.03 Million | 17.37 Million | -19.21 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -62.48 Million | -42.06 Million | -48.55 Million | -146.96 Million | -14.36 Million | -52.86 Million |
| Depreciation & Amortization | 2.02 Million | 1.9 Million | 1.46 Million | 3.56 Million | 891 Thousand | 895 Thousand |
| Deferred income taxes | - | - | - | -2.68 Million | -17.82 Million | 9.15 Million |
| Stock-based compensation | 14.9 Million | 14.34 Million | 11.96 Million | 43.11 Million | 10.89 Million | 11.65 Million |
| Change in working capital | 19.44 Million | -13.13 Million | -6.31 Million | 2.68 Million | 11.89 Million | 9.88 Million |
| Other non-cash items | -24.08 Million | 13.8 Million | 15.28 Million | -2.54 Million | -1.26 Million | -10.37 Million |
| Investing Cash Flow | -157.68 Million | 15.64 Million | -330.6 Million | 139.88 Million | 18.95 Million | 60.51 Million |
| Investments in PPE | 189 Thousand | -4.68 Million | -7.4 Million | -34.48 Million | -11.62 Million | -8.07 Million |
| Acquisitions | - | - | - | -5.22 Million | -30.57 Million | -68.58 Million |
| Investment purchases | -295.94 Million | -104.15 Million | -422.7 Million | -189.15 Million | -45.5 Million | -29.17 Million |
| Sales/Maturities of investments | 127.35 Million | 124.48 Million | 99.49 Million | 363.51 Million | 76.08 Million | 97.75 Million |
| Other Investing Activities | 10.71 Million | 20.33 Million | 3.07 Million | 5.22 Million | 30.57 Million | 68.58 Million |
| Financing Cash Flow | 250.91 Million | 1.41 Million | 353.75 Million | 4.19 Million | 1.93 Million | -206 Thousand |
| Debt repayment | -641 Thousand | -352 Thousand | -290 Thousand | -76 Thousand | -925 Thousand | -340 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -50.5 Million | 1.76 Million | 350.11 Million | 4.26 Million | 1 Million | 134 Thousand |
| Other Financing Activities | 302.06 Million | 1.76 Million | 52.67 Million | 4.26 Million | 1.85 Million | -206 Thousand |
| Accounts receivables | -327 Thousand | 327 Thousand | 15 Million | -15 Million | -14.98 Million | 344 Thousand |
| Accounts payables | 92 Thousand | 31 Thousand | 75 Thousand | 2.03 Million | 1.53 Million | 1.02 Million |
| Inventory | - | - | - | 23.37 Million | 14.98 Million | -344 Thousand |
| Other working capital | 21.46 Million | -13.49 Million | -7.97 Million | -7.72 Million | 10.36 Million | 8.86 Million |
| Cash at beginning of period | 67.61 Million | 93.51 Million | 109.96 Million | 74.52 Million | 86.84 Million | 58.18 Million |
| Cash at end of period | 116.5 Million | 67.61 Million | 93.51 Million | 115.77 Million | 115.77 Million | 86.84 Million |
| Capital Expenditure | 189 Thousand | -4.68 Million | -7.4 Million | -34.48 Million | -11.62 Million | -8.07 Million |
| Effect of forex changes on cash | - | - | - | - | 1000.00 | -18.28 Million |
| Net cash flow / Change in cash | 48.88 Million | -25.89 Million | -16.45 Million | 41.25 Million | 28.93 Million | 28.65 Million |
| Free Cash Flow | -50 Million | -47.62 Million | -46.99 Million | -137.3 Million | -3.58 Million | -39.72 Million |
GPW
FE
6923
3138
NTFL
SREI